Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: a scoping review by the OMERACT irAE working group

Introduction - Immune checkpoint inhibitors (ICI), increasingly used cancer therapeutics, can cause off-target inflammatory effects called immune-related adverse events (irAEs), including ICI-induced inflammatory arthritis (ICI-induced IA) and polymyalgia rheumatica (ICI-induced PMR). There are no v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ghosh, Nilasha (VerfasserIn) , Couette, Nina (VerfasserIn) , van Binsbergen, Wouter H. (VerfasserIn) , Weinmann, Sophia C. (VerfasserIn) , Jivanelli, Bridget (VerfasserIn) , Shea, Beverley (VerfasserIn) , Bass, Anne R. (VerfasserIn) , Gente, Karolina (VerfasserIn) , Bingham, Clifton O. (VerfasserIn) , Calabrese, Cassandra (VerfasserIn) , Cappelli, Laura C. (VerfasserIn) , Chan, Karmela Kim (VerfasserIn) , Choy, Ernest (VerfasserIn) , Daoussis, Dimitrios (VerfasserIn) , Goodman, Susan (VerfasserIn) , Hudson, Marie (VerfasserIn) , Jamal, Shahin (VerfasserIn) , Leipe, Jan (VerfasserIn) , Lopez-Olivo, Maria A. (VerfasserIn) , Suarez-Almazor, Maria (VerfasserIn) , van der Laken, Conny J. (VerfasserIn) , Meara, Alexa Simon (VerfasserIn) , Liew, David (VerfasserIn) , Kostine, Marie (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2023
In: Seminars in arthritis and rheumatism
Year: 2023, Jahrgang: 58, Pages: 1-8
ISSN:1532-866X
DOI:10.1016/j.semarthrit.2022.152110
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.semarthrit.2022.152110
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0049017222001615
Volltext
Verfasserangaben:Nilasha Ghosh, Nina Couette, Wouter H. van Binsbergen, Sophia C. Weinmann, Bridget Jivanelli, Beverley Shea, Anne R. Bass, Karolina Benesova, Clifton O. Bingham, Cassandra Calabrese, Laura C. Cappelli, Karmela Kim Chan, Ernest Choy, Dimitrios Daoussis, Susan Goodman, Marie Hudson, Shahin Jamal, Jan Leipe, Maria A. Lopez-Olivo, Maria Suarez-Almazor, Conny J. van der Laken, Alexa Simon Meara, David Liew, Marie Kostine

MARC

LEADER 00000caa a2200000 c 4500
001 1900940418
003 DE-627
005 20241205170203.0
007 cr uuu---uuuuu
008 240903s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.semarthrit.2022.152110  |2 doi 
035 |a (DE-627)1900940418 
035 |a (DE-599)KXP1900940418 
035 |a (OCoLC)1475309786 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ghosh, Nilasha  |e VerfasserIn  |0 (DE-588)1340819287  |0 (DE-627)1900941600  |4 aut 
245 1 0 |a Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica  |b a scoping review by the OMERACT irAE working group  |c Nilasha Ghosh, Nina Couette, Wouter H. van Binsbergen, Sophia C. Weinmann, Bridget Jivanelli, Beverley Shea, Anne R. Bass, Karolina Benesova, Clifton O. Bingham, Cassandra Calabrese, Laura C. Cappelli, Karmela Kim Chan, Ernest Choy, Dimitrios Daoussis, Susan Goodman, Marie Hudson, Shahin Jamal, Jan Leipe, Maria A. Lopez-Olivo, Maria Suarez-Almazor, Conny J. van der Laken, Alexa Simon Meara, David Liew, Marie Kostine 
264 1 |c February 2023 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 26. Oktober 2022, Artikelversion: 10. November 2022 
500 |a Gesehen am 03.09.2024 
520 |a Introduction - Immune checkpoint inhibitors (ICI), increasingly used cancer therapeutics, can cause off-target inflammatory effects called immune-related adverse events (irAEs), including ICI-induced inflammatory arthritis (ICI-induced IA) and polymyalgia rheumatica (ICI-induced PMR). There are no validated classification criteria or outcome measures for these conditions, and adaptation of treatment recommendations from corresponding rheumatic diseases may not be appropriate. We summarized clinical descriptors of ICI-induced IA and ICI-induced PMR and aggregated domains used for these conditions in order to inform the development of a core set of outcome domains. - Methods - As the initial step of the core domain set generation process, we systemically searched Medline (Pubmed), EMBASE, Cochrane, and CINHL through March 2021 to identify all studies that provide both clinical descriptions and domains relevant to ICI-induced IA and ICI-induced PMR. Domains were mapped to core areas, such as pathophysiological manifestations, life impact, resource use, and longevity/survival, as suggested by the OMERACT 2.1 Filter. - Results - We identified 69 publications, over a third of which utilized non-specific diagnoses of “arthritis,” “arthralgia,” and/or “PMR”. Other publications provided the number, the distribution and/or names of specific joints affected, while others labeled the irAE as the corresponding rheumatic disease, such as rheumatoid arthritis or spondyloarthritis. Most distinct domains mapped to the pathophysiology/manifestations core area (24 domains), such as signs/symptoms (13 domains), labs (6 domains), and imaging (5 domains), with harm domains of adverse effects from irAE treatment and fear of irAE treatment decreasing ICI efficacy. Forty-three publications also referenced irAE treatment and 35 subsequent response, as well as 32 tumor response. - Conclusion - There is considerable heterogeneity in the domains used to clinically characterize ICI-induced IA and ICI-induced PMR. There were several domains mapped to the pathophysiologic manifestations core area, although several publications highlighted domains evenly distributed among the other core areas of life impact, longevity/survival and resource use. 
650 4 |a ICI-induced inflammatory arthritis 
650 4 |a ICI-induced polymyalgia rheumatica 
650 4 |a Immune checkpoint inhibitor 
650 4 |a Outcome measures 
700 1 |a Couette, Nina  |e VerfasserIn  |4 aut 
700 1 |a van Binsbergen, Wouter H.  |e VerfasserIn  |4 aut 
700 1 |a Weinmann, Sophia C.  |e VerfasserIn  |4 aut 
700 1 |a Jivanelli, Bridget  |e VerfasserIn  |4 aut 
700 1 |a Shea, Beverley  |e VerfasserIn  |4 aut 
700 1 |a Bass, Anne R.  |e VerfasserIn  |4 aut 
700 1 |a Gente, Karolina  |d 1986-  |e VerfasserIn  |0 (DE-588)1066617481  |0 (DE-627)817734120  |0 (DE-576)426070216  |4 aut 
700 1 |a Bingham, Clifton O.  |e VerfasserIn  |4 aut 
700 1 |a Calabrese, Cassandra  |e VerfasserIn  |4 aut 
700 1 |a Cappelli, Laura C.  |e VerfasserIn  |4 aut 
700 1 |a Chan, Karmela Kim  |e VerfasserIn  |4 aut 
700 1 |a Choy, Ernest  |e VerfasserIn  |4 aut 
700 1 |a Daoussis, Dimitrios  |e VerfasserIn  |4 aut 
700 1 |a Goodman, Susan  |e VerfasserIn  |4 aut 
700 1 |a Hudson, Marie  |e VerfasserIn  |4 aut 
700 1 |a Jamal, Shahin  |e VerfasserIn  |4 aut 
700 1 |a Leipe, Jan  |d 1976-  |e VerfasserIn  |0 (DE-588)131797824  |0 (DE-627)51426280X  |0 (DE-576)298758563  |4 aut 
700 1 |a Lopez-Olivo, Maria A.  |e VerfasserIn  |4 aut 
700 1 |a Suarez-Almazor, Maria  |e VerfasserIn  |4 aut 
700 1 |a van der Laken, Conny J.  |e VerfasserIn  |4 aut 
700 1 |a Meara, Alexa Simon  |e VerfasserIn  |4 aut 
700 1 |a Liew, David  |e VerfasserIn  |4 aut 
700 1 |a Kostine, Marie  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Seminars in arthritis and rheumatism  |d Philadelphia, Pa. : Saunders, 1971  |g 58(2023) vom: Feb., Artikel-ID 152110, Seite 1-8  |h Online-Ressource  |w (DE-627)330079441  |w (DE-600)2048942-0  |w (DE-576)097935018  |x 1532-866X  |7 nnas  |a Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica a scoping review by the OMERACT irAE working group 
773 1 8 |g volume:58  |g year:2023  |g month:02  |g elocationid:152110  |g pages:1-8  |g extent:8  |a Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica a scoping review by the OMERACT irAE working group 
856 4 0 |u https://doi.org/10.1016/j.semarthrit.2022.152110  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0049017222001615  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240903 
993 |a Article 
994 |a 2023 
998 |g 131797824  |a Leipe, Jan  |m 131797824:Leipe, Jan  |d 60000  |d 61400  |e 60000PL131797824  |e 61400PL131797824  |k 0/60000/  |k 1/60000/61400/  |p 18 
998 |g 1066617481  |a Gente, Karolina  |m 1066617481:Gente, Karolina  |d 910000  |d 910100  |e 910000PG1066617481  |e 910100PG1066617481  |k 0/910000/  |k 1/910000/910100/  |p 8 
999 |a KXP-PPN1900940418  |e 4574043636 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica","title_sort":"Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica","subtitle":"a scoping review by the OMERACT irAE working group"}],"recId":"1900940418","type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"name":{"displayForm":["Nilasha Ghosh, Nina Couette, Wouter H. van Binsbergen, Sophia C. Weinmann, Bridget Jivanelli, Beverley Shea, Anne R. Bass, Karolina Benesova, Clifton O. Bingham, Cassandra Calabrese, Laura C. Cappelli, Karmela Kim Chan, Ernest Choy, Dimitrios Daoussis, Susan Goodman, Marie Hudson, Shahin Jamal, Jan Leipe, Maria A. Lopez-Olivo, Maria Suarez-Almazor, Conny J. van der Laken, Alexa Simon Meara, David Liew, Marie Kostine"]},"note":["Online verfügbar: 26. Oktober 2022, Artikelversion: 10. November 2022","Gesehen am 03.09.2024"],"person":[{"given":"Nilasha","role":"aut","display":"Ghosh, Nilasha","roleDisplay":"VerfasserIn","family":"Ghosh"},{"given":"Nina","role":"aut","display":"Couette, Nina","roleDisplay":"VerfasserIn","family":"Couette"},{"roleDisplay":"VerfasserIn","family":"van Binsbergen","display":"van Binsbergen, Wouter H.","role":"aut","given":"Wouter H."},{"given":"Sophia C.","display":"Weinmann, Sophia C.","role":"aut","roleDisplay":"VerfasserIn","family":"Weinmann"},{"given":"Bridget","display":"Jivanelli, Bridget","role":"aut","family":"Jivanelli","roleDisplay":"VerfasserIn"},{"display":"Shea, Beverley","role":"aut","given":"Beverley","roleDisplay":"VerfasserIn","family":"Shea"},{"given":"Anne R.","role":"aut","display":"Bass, Anne R.","roleDisplay":"VerfasserIn","family":"Bass"},{"roleDisplay":"VerfasserIn","family":"Gente","role":"aut","display":"Gente, Karolina","given":"Karolina"},{"roleDisplay":"VerfasserIn","family":"Bingham","given":"Clifton O.","display":"Bingham, Clifton O.","role":"aut"},{"display":"Calabrese, Cassandra","role":"aut","given":"Cassandra","family":"Calabrese","roleDisplay":"VerfasserIn"},{"given":"Laura C.","role":"aut","display":"Cappelli, Laura C.","family":"Cappelli","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Chan, Karmela Kim","given":"Karmela Kim","family":"Chan","roleDisplay":"VerfasserIn"},{"family":"Choy","roleDisplay":"VerfasserIn","given":"Ernest","display":"Choy, Ernest","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Daoussis","given":"Dimitrios","role":"aut","display":"Daoussis, Dimitrios"},{"family":"Goodman","roleDisplay":"VerfasserIn","given":"Susan","role":"aut","display":"Goodman, Susan"},{"family":"Hudson","roleDisplay":"VerfasserIn","given":"Marie","display":"Hudson, Marie","role":"aut"},{"family":"Jamal","roleDisplay":"VerfasserIn","given":"Shahin","role":"aut","display":"Jamal, Shahin"},{"given":"Jan","display":"Leipe, Jan","role":"aut","roleDisplay":"VerfasserIn","family":"Leipe"},{"given":"Maria A.","role":"aut","display":"Lopez-Olivo, Maria A.","roleDisplay":"VerfasserIn","family":"Lopez-Olivo"},{"role":"aut","display":"Suarez-Almazor, Maria","given":"Maria","family":"Suarez-Almazor","roleDisplay":"VerfasserIn"},{"display":"van der Laken, Conny J.","role":"aut","given":"Conny J.","roleDisplay":"VerfasserIn","family":"van der Laken"},{"roleDisplay":"VerfasserIn","family":"Meara","given":"Alexa Simon","display":"Meara, Alexa Simon","role":"aut"},{"given":"David","display":"Liew, David","role":"aut","family":"Liew","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Kostine, Marie","given":"Marie","roleDisplay":"VerfasserIn","family":"Kostine"}],"physDesc":[{"extent":"8 S."}],"relHost":[{"id":{"issn":["1532-866X"],"eki":["330079441"],"zdb":["2048942-0"]},"origin":[{"publisherPlace":"Philadelphia, Pa.","dateIssuedKey":"1971","publisher":"Saunders","dateIssuedDisp":"1971-"}],"note":["Gesehen am 21.02.20"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1971 -"],"part":{"extent":"8","year":"2023","pages":"1-8","text":"58(2023) vom: Feb., Artikel-ID 152110, Seite 1-8","volume":"58"},"title":[{"title_sort":"Seminars in arthritis and rheumatism","title":"Seminars in arthritis and rheumatism"}],"disp":"Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica a scoping review by the OMERACT irAE working groupSeminars in arthritis and rheumatism","recId":"330079441"}],"id":{"doi":["10.1016/j.semarthrit.2022.152110"],"eki":["1900940418"]},"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"February 2023"}]} 
SRT |a GHOSHNILASIDENTIFICA2023